Atraverse Medical Showcases HOTWIRE Data Indicating Safer, More Efficient Left-Heart Access

New updates have been reported about Atraverse Medical.

Atraverse Medical unveiled new clinical and preclinical results at AF Symposium 2026 in Boston, placing its HOTWIRE™ Transseptal Access System at the center of growing evidence for safer, more controlled left-heart access. Across three separate presentations, investigators reported reduced unintended tissue damage, shorter radiofrequency (RF) delivery times, and consistent performance in diverse workflows, underscoring the potential for the system to reshape transseptal access practices.

In an ex vivo porcine model, HOTWIRE’s large-electrode, impedance-guided RF system recorded zero unintended left atrial injuries, compared with more than 50% injury rates using a small-electrode RF guidewire, while also lowering RF duration and total energy. First-in-human, multicenter data in about 500 patients showed 100% procedural success with low RF exposure and a simplified zero-exchange workflow, and an additional series covering more than 1,000 transseptal procedures again achieved 100% success with no reported adverse events and 29% of cases performed without fluoroscopy, highlighting operational efficiencies and radiation-sparing potential.

Atraverse’s HOTWIRE platform pairs a novel RF guidewire with a next-generation RF generator that uses impedance sensing to automatically stop energy delivery once the left atrium is crossed, seeking to mitigate avoidable RF exposure and left atrial injury. The RF guidewire is compatible with a wide range of sheaths and is engineered with enhanced echocardiographic visibility and increased rail stiffness to support controlled advancement of large-bore devices, aiming to integrate seamlessly into existing structural heart and electrophysiology workflows.

Co-founder and Chief Translational Science Officer Dr. Steven Mickelsen said the consistent results from preclinical and first-in-human studies highlight the importance of controlled RF delivery and support HOTWIRE’s potential to set a new standard for left-heart access. For executives and investors, the growing dataset strengthens Atraverse Medical’s positioning as a differentiated left-heart access platform in a large and procedure-intensive cardiovascular market, providing a clinical and workflow value proposition that could drive adoption as the company advances commercialization plans.